Polymorphisms in the CCR5 and CCR2 genes and their Frequencies in the Middle Eastern Population

Main Article Content

Murtadha M-Hussein A-Kadhim

Abstract

Background: The expression of proteins, and consequently the course of HIV-1 illness, can be influenced by the polymorphisms that can be detected in the CCR5 gene's regulatory region. As a result of this major role, variants in this gene have been subjected to diverse pressures, which has led to differences in the frequency at which they occur among human populations. There is a strong correlation between polymorphisms in the CCR2V64I mutation and CCR5 gene. As a consequence of their long history as merchants who dominated large areas within and around the Indian Ocean, the people who currently live in the Middle East have a diversified genetic makeup.


Methods:  In this particular piece of research, we investigated the CCR2-CCR5 haplotypes that are found in the Middle East and compared the genetic diversity patterns of these haplotypes to those found in other populations.


Results: A total of one hundred adults from the Middle East had blood samples taken from them, and their genomic DNA was analyzed to look for polymorphism locations in the CCR5 gene as well as the CCR2V64I mutation. The frequencies of CCR5-2554T was 49% and CCR5-2086G 46%, while the frequencies of CCR5-2459A and CCR5-2135C were 36%.


Conclusions: These alleles displayed a modest degree of heterozygosity, which is an indication that balancing selection was acting upon them. On the other side, the well-known allele CCR532 was far less prevalent than expected. Eleven different haplotypes were discovered, with four of them being particularly prevalent: HHC, HH, HHA, and HHF*2. (46%, 20%, 14% and 12%) respectively.

Article Details

How to Cite
A-Kadhim, M. M.-H. . (2023). Polymorphisms in the CCR5 and CCR2 genes and their Frequencies in the Middle Eastern Population. International Journal of Pharmaceutical and Bio Medical Science, 3(04), 162–169. https://doi.org/10.47191/ijpbms/v3-i4-02
Section
Articles

References

I. Pei Yu, Bingmei Liu, Siyu Hao, Ronggui Xing, and Yuzhen Li. A New Risk Polymorphism rs10403848 of CARD8. Significantly Associated with Psoriasis Vulgaris in Northeastern China. BioMed Research International Volume 6, 2020, Article ID 2867505, 7 pages.

II. Guo-wen Ding, Xu-yu Gu , Zhe Dai , Hui-wen Pan , Xiao-yan Wang , Heng Zhang , and Yu Fan. Association of Genetic Polymorphisms in FOXA1 with the Progression of Genetic Susceptibility to Gastric Cancer. Gastroenterology Research and Practice,Volume 4, 2020, Article ID 3075837, 8 pages.

III. Ngoufack MN, Nkenfou CN, Atogho Tiedeu B, Mouafo LCM, Dambaya B, Ndzi EN, Kouanfack C, Nguefack-Tsague G, Mbacham WF, Ndjolo A. CCR2 Genetic Polymorphism And Its Potential Effect On HIV Acquisition In A Population Of Children Living In The Northern Region Of Cameroon. Journal of The Application of Clinical Genetics, Volume 12, 2019:12 Pages 229 - 234.

IV. Cheryl L. Laffer, James V. Gainer, Michael R. Waterman, Jorge H. Capdevila, Michal Laniado-Schwartzman, Alberto Nasjletti, Nancy J. Brown, and Fernando Elijovich. The T8590C Polymorphism of CYP4A11 and 20-Hydroxyeicosatetraenoic Acid in Essential Hypertension. Hypertension, 2008 Mar; 51(3): 767–772.

V. Arthur P. Ruiz, David O. Ajasin, Santhamani Ramasamy, Vera DesMarais, Eliseo A. Eugenin & Vinayaka R. A Naturally Occurring Polymorphism in the HIV-1 Tat Basic Domain Inhibits Uptake by Bystander Cells and Leads to 21 ReducedNeuroinflammation.Scientific, Reports,2019;9:3308https://doi.org/10.1038/s41598-019-39531-5.

VI. Global HIV & AIDS statistics UNAIDS 2021.

VII. Simon J.H., Somoza C., Schockmel G.A., et al. Rat CD4 mutant containing the gp120-binding site mediates human immunodeficiency virus type 1 infection. J. Exp. Med 1993; 177:949-54.

VIII. Clapham P.R., Blanc D., Weiss R.A. Specific cell surface requirements for the infection of CD4-positive cells by human immunodeficiency virus types 1 and 2 and by Simian immunodeficiency virus. Virology 1991; 181:703-15.

IX. Horuk R. Molecular properties of the chemokine receptor family. Trends Pharmacol Sci 1994; 15:159-65.

X. Schall T.J. Biology of the RANTES/SIS cytokine family. Cytokine 1991; 3:165-8.

XI. Samson M., Labbe O., Mollereau C., et al. Molecular cloning and functional expression of a new human CC-chemokine receptor gene. Biochemistry 1996; 35:3362-7.

XII. D‟Souza M.P., Harden V.A. Chemokines and HIV-1 second receptors. Confluence of two fields generates optimism in AIDS research. Nat Med 1996; 2:1293-300.

XIII. Koot M., Van„t Wout A.B., Kootstra N.A., et al. Relation between changes in cellular load, evolution of viral phenotype, and the clonal composition of virus populations in the course of human immunodeficiency virus type 1 infection. J Infect Dis 1996; 173:349-54 22

XIV. Paxton W., Martin S.R., Tse D., et al. Relative resistance to HIV-1 infection of CD4 lymphocytes from persons who remain uninfected despite multiple high risk sexual exposure. Nat Med 1996; 2:412-7.

XV. McLaren PJ, Fellay J. HIV-1 and human genetic variation. Nat Rev Genet. 2021 Jun 24:1–13. doi: 10.1038/s41576-021-00378-0. Epub ahead of print. PMID: 34168330; PMCID: PMC8223526.

XVI. Liu R., Paxton W.A., Choe S., et al. Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply exposed individuals. Revista 1996.

XVII. Rowland-Jones S., Sutton J., Ariyoshi K., et al. HIV-specific cytotoxic T-cells in HIV-exposed but uninfected Gambian women. Nat Med 1995; 1:50-64.

XVIII. Wilkinson D.A., Operskalski E.A., Busch M.P., et al. A 32-bp deletion within the CCR5 locus protects against transmission of parenterally acquired human immunodeficiency virus but does not affect progression to AIDS-defining illness. J Infect Dis 1998; 178:1163-6.

XIX. Zimmerman P.A., Buckler-White A., Alkhatib G., et al. Inherited resistance to HIV-1 conferred by an inactivating mutation in CC chemokine receptor 5; Studies in populations with contrasting clinical phenotypes, defined racial background, and quantified risk. Mol. Med 1997; 3:23-36.

XX. Smith M.W., Dean M., Carrington M., et al. Contrasting genetic influence of CCR2 and CCR5 variants on HIV-1 infection and disease progression. Science 1997;15;277(5328):959-65. 23

XXI. Ronsard L, Sood V, Yousif AS, Ramesh J, Shankar V, Das J, Sumi N, Rai T, Mohankumar K, Sridharan S, Dorschel A, Ramachandran VG, Banerjea AC. Genetic Polymorphisms in the Open Reading Frame of the CCR5 gene from HIV-1 Seronegative and Seropositive Individuals From National Capital Regions of India. Sci Rep. 2019 May 20;9(1):7594. doi: 10.1038/s41598-019-44136-z. PMID: 31110236; PMCID: PMC6527560.

XXII. Mummidi S, Bamshad M, Ahuja SS, Gonzalez E, Feuillet PM, Begum K, Galvis MC, Kostecki V, Valente AJ, Murthy KK, et al. Evolution of human and non-human primate CC chemokine receptor 5 gene and mRNA. Potential roles for haplotype and mRNA diversity, differential haplotype-specific transcriptional activity, and altered transcription factor binding to polymorphic nucleotides in the pathogenesis of HIV-1 and simian immunodeficiency virus. J Biol Chem. 2000; 275:18946–18961.

XXIII. Peakall ROD, Smouse PE. Genalex 6: Genetic analysis in Excel. Population genetic software for teaching and research. Mol Ecol Notes. 2006; 6:288–295.

XXIV. Excoffier LG, Schneider S. An integrated software package for population genetics data analysis. Evol Bioinform Online. 2005; 1:47–50.

XXV. Stephens M, Donnelly P. A comparison of Bayesian methods for haplotype reconstruction from population genotype data. Am J Hum Genet. 2003; 73:1162–1169.

XXVI. Bandelt HJ, Forster P, Röhl A. Median-joining networks for inferring intraspecific phylogenies. Mol Biol Evol. 1999; 16:37–48.

XXVII. Saitou N, Nei M. The neighbor-joining method: A new method for reconstructing phylogenetic trees. Mol Biol Evol. 1987; 4:406–425.

XXVIII. J.H. Abramson, P.M. Gahlinger, Computer Program forEpidemiologists, PEPI version 3, Brixton Books, London,1999.